title: Clustering gene expression regulators: new approach to disease subtyping.
abstract: One of the main challenges in modern medicine is to stratify different patient groups in terms of underlying disease molecular mechanisms as to develop more personalized approach to therapy. Here we propose novel method for disease subtyping based on analysis of activated expression regulators on a sample-by-sample basis. Our approach relies on Sub-Network Enrichment Analysis algorithm (SNEA) which identifies gene subnetworks with significant concordant changes in expression between two conditions. Subnetwork consists of central regulator and downstream genes connected by relations extracted from global literature-extracted regulation database. Regulators found in each patient separately are clustered together and assigned activity scores which are used for final patients grouping. We show that our approach performs well compared to other related methods and at the same time provides researchers with complementary level of understanding of pathway-level biology behind a disease by identification of significant expression regulators. We have observed the reasonable grouping of neuromuscular disorders (triggered by structural damage vs triggered by unknown mechanisms), that was not revealed using standard expression profile clustering. For another experiment we were able to suggest the clusters of regulators, responsible for colorectal carcinoma vs adenoma discrimination and identify frequently genetically changed regulators that could be of specific importance for the individual characteristics of cancer development. Proposed approach can be regarded as biologically meaningful feature selection, reducing tens of thousands of genes down to dozens of clusters of regulators. Obtained clusters of regulators make possible to generate valuable biological hypotheses about molecular mechanisms related to a clinical outcome for individual patient.
authors.affiliation: Institute of Biomedical Chemistry, RAMS, Moscow, Russia ; Ariadne Diagnostics LLC, Rockville, Maryland, United States of America.
authors.forename: Mikhail
authors.initials: M
authors.lastname: Pyatnitskiy
authors.affiliation: Ariadne Diagnostics LLC, Rockville, Maryland, United States of America.
authors.forename: Ilya
authors.initials: I
authors.lastname: Mazo
authors.affiliation: Elsevier Inc, Rockville, Maryland, United States of America.
authors.forename: Maria
authors.initials: M
authors.lastname: Shkrob
authors.affiliation: Ariadne Diagnostics LLC, Rockville, Maryland, United States of America.
authors.forename: Elena
authors.initials: E
authors.lastname: Schwartz
authors.affiliation: Ariadne Diagnostics LLC, Rockville, Maryland, United States of America ; Institute for Information Transmission Problems, RAS, Moscow, Russia.
authors.forename: Ekaterina
authors.initials: E
authors.lastname: Kotelnikova
mesh_terms: D000236:Adenoma / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D000465:Algorithms; D002277:Carcinoma / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D016000:Cluster Analysis; D015179:Colorectal Neoplasms / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D003937:Diagnosis, Differential; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D053263:Gene Regulatory Networks; D006801:Humans; D005810:Multigene Family; D009468:Neuromuscular Diseases / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D057285:Precision Medicine